BioCorRx (BICX) Selling, General & Administrative (2010 - 2026)
BioCorRx's Selling, General & Administrative was $775,453 in Q1 2026, down 12.5% from $886,083 a year earlier but up 43.8% from the prior quarter.
Powered by 
Analysis
BioCorRx (BICX) Selling, General & Administrative (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, BioCorRx's Selling, General & Administrative was $3.68 million through Mar 31, 2026, down 1.7% year-over-year; for FY2025, it came in at $3.79 million, up 5.0% from FY2024.
- Selling, General & Administrative shows a five-year compound annual growth rate of 3.7% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $3.61 million in FY2024 (+25.6%), $2.88 million in FY2023 (-15.7%), $3.41 million in FY2022 (-8.9%) and $3.74 million in FY2021 (+18.1%).
- Quarterly Selling, General & Administrative has moved between $539,366 (Q4 2025) and $1.22 million (Q2 2025) over five years.
- Compared with a year earlier, Selling, General & Administrative has declined for three straight quarters, with growth averaging 16.0% over the last eight quarters.
- The best year-over-year quarter for Selling, General & Administrative over five years was Q3 2024 (growth of 76.9%); the worst was Q4 2025 (a decline of 35.7%).
- Per Business Quant data, BICX's Selling, General & Administrative in the three quarters before Q1 2026 was $539,366 (Q4 2025), $1.15 million (Q3 2025) and $1.22 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | BioCorRx | 3.46 Mn | 2.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 775,453.00 |
| Dec 31, 2025 | 539,366.00 |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 886,083.00 |
| Dec 31, 2024 | 839,193.00 |
| Sep 30, 2024 | 1.19 Mn |
| Jun 30, 2024 | 830,321.00 |
| Mar 31, 2024 | 750,098.00 |
| Dec 31, 2023 | 693,587.00 |
| Sep 30, 2023 | 674,456.00 |
| Jun 30, 2023 | 711,027.00 |
| Mar 31, 2023 | 796,049.00 |
| Dec 31, 2022 | 717,075.00 |
| Sep 30, 2022 | 771,810.00 |
| Jun 30, 2022 | 981,819.00 |
| Mar 31, 2022 | 938,945.00 |
| Dec 31, 2021 | 1.10 Mn |
| Sep 30, 2021 | 892,232.00 |
| Jun 30, 2021 | 834,726.00 |
API Access
BioCorRx Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();